Hints and tips:
Related Special Reports
...Ugur Sahin, BioNTech’s chief executive, said the study suggested that the lower dose “provides young children with a high level of protection against the recent Covid-19 strains”....
...A version of this article was first published by Nikkei Asia on February 14 2023. ©2023 Nikkei Inc. All rights reserved....
...“Although young children are at lower risk for severe Covid-19, they’re not at no risk — many children under the age of five have been hospitalised and some have died of Covid-19....
...Sonja Rasmussen, professor at the University of Florida College of Medicine, said it is critical that the studies show the vaccine is not only safe, but that it is effective and that it works in this young...
...“It’s the brave and bold attitude of young Koreans who have confidence to pick what’s cool out there, remix it and call it theirs....
...And the enthusiasm levels have gone up recently among the young and among women. And let’s not overlook the backlash to the Supreme Court rule, the Dobbs ruling on scrapping Roe v Wade....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Albert Bourla, Pfizer chair and chief executive, said the authorisation by the FDA was a day that many parents, eager to protect their young children from the virus, had anticipated....
...The FDA declined to comment on Pfizer’s application....
...Unveiling the plan, health secretary Sajid Javid made clear that Covid vaccination for adults, and young people whose health is vulnerable, was the priority, alongside immunisation programmes against childhood...
...“Covid-19 is an ongoing threat for the more than 28m young children in this age group in the US, as they remain at risk for this infection,” she said....
...The letter was sent to the boards of Pfizer, Moderna, AstraZeneca and Johnson & Johnson....
...The BioNTech/Pfizer jab will be dispensed in “kid-sized” doses, a third of the size of those for people aged 12 years and more....
...On Tuesday, Pfizer offered the first glimpse of its intended timeline for authorisation of the jab in infants as young as six months old....
...Reach out to me (imani.moise@ft.com) or Sid (sid.v@ft.com) to let us know. Happy reading!...
...My two mixed-breed dogs, Pfizer and AstraZeneca, adopted during the pandemic, climb on my knees, asking to be stroked....
...Several committee members expressed concern during the meeting about approving a booster dose for everyone aged 16 and over, given reports of rare cases of heart problems suffered by young people following...
...Pfizer and BioNTech started enrolling participants in their phase 1 study in September....
...“He called me 30 times, asking: ‘What about young people . . . what are you doing about the South African variant?’...
...“Pretty much what we see in young adults is also seen in adolescents . . . We don’t think at this point in time that something different will happen,” Cavaleri said....
...Jabs would be needed by those who were previously too young to receive them. For the rest, much depends on whether efficacy significantly wanes over time....
...All of the big western pharmaceutical companies are trialling their jabs in children, some as young as six months old....
...Last week, they reported that a phase 3 trial of the jab on 2,260 young teenagers aged 12 to 15 had shown 100 per cent efficacy and a strong antibody response....
...Pfizer and BioNTech last week began administering doses in their first trial of children aged 11 and under. The vaccine could ultimately be tested on babies as young as six months old....
...The western pharmaceutical companies that produce coronavirus vaccines are at various stages of carrying out trials of their shots on children, some as young as six months, although Pfizer and BioNTech are...
International Edition